171 related articles for article (PubMed ID: 29174677)
1. In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8
Sales NS; Silva JR; Aps LRMM; Silva MO; Porchia BFMM; Ferreira LCS; Diniz MO
Vaccine; 2017 Dec; 35(52):7240-7249. PubMed ID: 29174677
[TBL] [Abstract][Full Text] [Related]
2. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.
Best SR; Peng S; Juang CM; Hung CF; Hannaman D; Saunders JR; Wu TC; Pai SI
Vaccine; 2009 Sep; 27(40):5450-9. PubMed ID: 19622402
[TBL] [Abstract][Full Text] [Related]
3. Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital Tract.
Sun YY; Peng S; Han L; Qiu J; Song L; Tsai Y; Yang B; Roden RB; Trimble CL; Hung CF; Wu TC
Clin Cancer Res; 2016 Feb; 22(3):657-69. PubMed ID: 26420854
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors.
Sun Y; Peng S; Qiu J; Miao J; Yang B; Jeang J; Hung CF; Wu TC
Gene Ther; 2015 Jul; 22(7):528-35. PubMed ID: 25786869
[TBL] [Abstract][Full Text] [Related]
5. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
6. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
Diniz MO; Cariri FA; Aps LR; Ferreira LC
Hum Gene Ther; 2013 Oct; 24(10):861-70. PubMed ID: 24007495
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection.
Jiang RT; Wang JW; Peng S; Huang TC; Wang C; Cannella F; Chang YN; Viscidi RP; Best SRA; Hung CF; Roden RBS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515303
[TBL] [Abstract][Full Text] [Related]
8. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A
Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434
[TBL] [Abstract][Full Text] [Related]
10. Antitumor therapeutic and antimetastatic activity of electroporation-delivered human papillomavirus 16 E7 DNA vaccines: a possible mechanism for enhanced tumor control.
Lee IH; Park JB; Cheong M; Choi YS; Park D; Sin JI
DNA Cell Biol; 2011 Dec; 30(12):975-85. PubMed ID: 21649506
[TBL] [Abstract][Full Text] [Related]
11. Enhanced immunogenicity and protective efficacy of a tetravalent dengue DNA vaccine using electroporation and intradermal delivery.
Williams M; Ewing D; Blevins M; Sun P; Sundaram AK; Raviprakash KS; Porter KR; Sanders JW
Vaccine; 2019 Jul; 37(32):4444-4453. PubMed ID: 31279565
[TBL] [Abstract][Full Text] [Related]
12. Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.
Kang TH; Chung JY; Monie A; Pai SI; Hung CF; Wu TC
Gene Ther; 2010 Apr; 17(4):531-40. PubMed ID: 19940864
[TBL] [Abstract][Full Text] [Related]
13. Protection against HPV-16-Associated Tumors Requires the Activation of CD8+ Effector Memory T Cells and the Control of Myeloid-Derived Suppressor Cells.
Diniz MO; Sales NS; Silva JR; Ferreira LC
Mol Cancer Ther; 2016 Aug; 15(8):1920-30. PubMed ID: 27222537
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.
Ma Y; Yang A; Peng S; Qiu J; Farmer E; Hung CF; Wu TC
Vaccine; 2017 Jul; 35(31):3850-3858. PubMed ID: 28599791
[TBL] [Abstract][Full Text] [Related]
15. Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.
Lamolinara A; Stramucci L; Hysi A; Iezzi M; Marchini C; Mariotti M; Amici A; Curcio C
J Immunol Res; 2015; 2015():159145. PubMed ID: 26247038
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.
Kang TH; Monie A; Wu LS; Pang X; Hung CF; Wu TC
Vaccine; 2011 Jan; 29(5):1082-9. PubMed ID: 21130752
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines, electroporation and their applications in cancer treatment.
Lee SH; Danishmalik SN; Sin JI
Hum Vaccin Immunother; 2015; 11(8):1889-900. PubMed ID: 25984993
[TBL] [Abstract][Full Text] [Related]
18. Electroporation enhances protective immune response of a DNA vaccine against Japanese encephalitis in mice and pigs.
Sheng Z; Gao N; Cui X; Fan D; Chen H; Wu N; Wei J; An J
Vaccine; 2016 Nov; 34(47):5751-5757. PubMed ID: 27743649
[TBL] [Abstract][Full Text] [Related]
19. Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells.
Choi YW; Kang MC; Seo YB; Namkoong H; Park Y; Choi DH; Suh YS; Lee SW; Sung YC; Jin HT
Clin Cancer Res; 2016 Dec; 22(23):5898-5908. PubMed ID: 27407095
[TBL] [Abstract][Full Text] [Related]
20. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
Esquerré M; Momot M; Goubier A; Gonindard C; Leung-Theung-Long S; Misseri Y; Bissery MC
Vaccine; 2017 Mar; 35(11):1509-1516. PubMed ID: 28196735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]